122 related articles for article (PubMed ID: 18441495)
1. [Advance prediction of Mild Cognitive Impairment (MCI) using (99m)Tc-ECD SPECT brain blood flow imaging].
Kawasaki Y
Nihon Ronen Igakkai Zasshi; 2008 Mar; 45(2):202-12. PubMed ID: 18441495
[TBL] [Abstract][Full Text] [Related]
2. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
3. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
4. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
[TBL] [Abstract][Full Text] [Related]
5. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic approach with Z-score mapping to reduce artifacts caused by cerebral atrophy in regional CBF assessment of mild cognitive impairment (MCI) and Alzheimer's disease by [
Odano I; Maeyatsu F; Hosoya T; Asari M; Oba K; Taki Y
Jpn J Radiol; 2024 May; 42(5):508-518. PubMed ID: 38351252
[TBL] [Abstract][Full Text] [Related]
7. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
8. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
[TBL] [Abstract][Full Text] [Related]
9. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status.
Tu MC; Lo CP; Chen CY; Huang CF
BMC Neurol; 2015 Dec; 15():251. PubMed ID: 26630935
[TBL] [Abstract][Full Text] [Related]
11. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
[TBL] [Abstract][Full Text] [Related]
12. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
[TBL] [Abstract][Full Text] [Related]
13. Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
Terada S; Sato S; Nagao S; Ikeda C; Shindo A; Hayashi S; Oshima E; Yokota O; Uchitomi Y
Psychiatry Res; 2013 Sep; 213(3):249-55. PubMed ID: 23830931
[TBL] [Abstract][Full Text] [Related]
14. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
[TBL] [Abstract][Full Text] [Related]
15. Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment.
Yoon HJ; Park KW; Jeong YJ; Kang DY
Nucl Med Commun; 2012 Aug; 33(8):848-58. PubMed ID: 22692580
[TBL] [Abstract][Full Text] [Related]
16. SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment.
Pappatà S; Varrone A; Vicidomini C; Milan G; De Falco C; Sansone V; Iavarone A; Comerci M; Loré E; Panico MR; Quarantelli M; Postiglione A; Salvatore M
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1156-63. PubMed ID: 20306034
[TBL] [Abstract][Full Text] [Related]
17. Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report.
Chen JJ; Shiau YC; Wang JJ; Ho ST; Kao A
Scand J Rheumatol; 2002; 31(2):89-93. PubMed ID: 12109653
[TBL] [Abstract][Full Text] [Related]
18. The need of appropriate brain SPECT templates for SPM comparisons.
Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m-ECD SPECT as the measure for therapeutic response in patients with cobalamin deficiency: Two case reports.
Tu MC; Lo CP; Chen CY
Medicine (Baltimore); 2016 Sep; 95(39):e4851. PubMed ID: 27684816
[TBL] [Abstract][Full Text] [Related]
20. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study.
Le Guern V; Belin C; Henegar C; Moroni C; Maillet D; Lacau C; Dumas JL; Vigneron N; Guillevin L
Ann Rheum Dis; 2010 Jan; 69(1):132-7. PubMed ID: 19158115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
